KZA kazia therapeutics limited
Add to My Watchlist 0.00% ! 8.0¢

News: KZA PNOC Clinical Study Of Kazia's Paxalisib In Childhood Brain Cancer Expands Internationally

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    06/10/22
    23:45
    Post #: 64074241

    Oct 6 (Reuters) - Kazia Therapeutics Ltd (KZA) :

    • PNOC CLINICAL STUDY OF KAZIA'S PAXALISIB IN CHILDHOOD BRAIN CANCER EXPANDS INTERNATIONALLY
    • KAZIA THERAPEUTICS LTD - KAZIA ANTICIPATES INITIAL DATA FROM ONGOING PNOC022 STUDY IN CY2023
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BML Boab Metals secures path to full ownership of Sorby Hills Project
right-arrow Created with Sketch.
MEM Memphasys secures transformational A$325K initial order with exclusive Middle East partnership
right-arrow Created with Sketch.
NEWS How to handle a financial crisis and turn setbacks into setups
right-arrow Created with Sketch.
NEWS Outstanding thick high-grade gold revealed in first Greenewood assays
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner
right-arrow Created with Sketch.
NEWS The 4 sectors poised to benefit from Australia's immigration wave
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.